DR.NOON
LIVE

Serial Number

79421833

Owner

Mediwhale Inc.

Attorney

Rui Geissler

Filing Date

Jan 16, 2025

Add to watchlist:

No watchlists yet
View on USPTO

DR.NOON Trademark

Serial Number: 79421833

DR.NOON is a trademark filed by Mediwhale Inc. on January 16, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Mediwhale Inc. (6 trademarks)

#906, 43, Digital-ro 34-gil,

Entity Type: 03

Trademark Details

Filing Date

January 16, 2025

Registration Date

Not Registered

Goods & Services

Providing access to databases; transmission and reception of information and data via telecommunication networks; electronic transmission of digital image; providing user access to a global computer network via mobile devices; providing the transmission of information via on-line network; electronic transmission of text, photo and video via smartphone applications; electronic transmission and delivery of audio and visual content; providing access to proprietary collections of medical and health information via website; transmission and reception of database information via wired or wireless telecommunication networks; providing access to web sites featuring medical information on the internet; providing access to proprietary collections of information on the internet; transmission of information via the internet; transmission of information; transmission of data via a computer network; providing access to computer databases; providing of telecommunications connections for cloud services; provision of access to medical information via the internet.

Retinal cameras other than for medical use; tonometers for measuring, not for medical purposes; biometric retinal scanners; downloadable application software for smartphones featuring information for use in ophthalmic disease diagnosis, surgery and treatment; microscope for ophthalmic surgery; humanoid robot equipped with artificial intelligence for ophthalmic diagnosis, surgery and treatment; downloadable artificial intelligence program and software featuring information for use in ophthalmic disease diagnosis, surgery and treatment; recorded artificial intelligence program and software featuring information for use in ophthalmic disease diagnosis, surgery and treatment; wearable computer equipped with artificial intelligence which provides information for ophthalmic disease diagnosis, surgery and treatment; computers equipped with artificial intelligence which provides information for ophthalmic disease diagnosis, surgery and treatment; downloadable software for analyzing medical images for use in disease diagnosis and for use in medical decision support systems; computers and computer hardware for medical purposes; humanoid robots with artificial intelligence for use in scientific research; computers and computer hardware; downloadable computer software for collecting, processing, analyzing, managing, storing, and displaying data and digital images; recorded computer software for collecting, processing, analyzing, managing, storing, and displaying data and digital images; computer servers; peripherals adapted for use with computers; wearable computers in the nature of smartwatches and smartglasses; downloadable computer application software for smartphones, namely, software for collecting, processing, analyzing, managing, storing, transmitting, and displaying data and digital images; recorded software for analyzing medical images for use in disease diagnosis and for use in medical decision support systems

Systematization of data in computer databases; wholesale store services featuring data processing software; retail store services featuring data processing software; compiling of information into computer databases; collection and systematisation of information into computer databases; wholesale store services featuring artificial intelligence programs and software for medical use; retail store services featuring artificial intelligence programs and software for medical use; sales agency services, namely, retail services by direct solicitation by sales agents featuring artificial intelligence programs and software for medical use; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; sales agency services, namely, retail services by direct solicitation by sales agents for medical apparatus and instruments; marketing the medical device goods of others; wholesale store services featuring apparatus for analysing images for medical use; retail store services featuring apparatus for analysing images for medical use; sales agency services, namely, retail services by direct solicitation by sales agents and wholesale and retail distribution services for apparatus for analysing images for medical use; wholesale store services featuring software for diagnosing diseases for medical purposes; retail store services featuring software for diagnosing diseases for medical purposes; sales agency services, namely, retail services by direct solicitation by sales agents for software for diagnosing diseases for medical purposes; wholesale store services featuring software for use in medical decision support systems; retail store services featuring software for use in medical decision support systems; sales agency services, namely, retail services by direct solicitation by sales agents for software for use in medical decision support systems; wholesale store services featuring software for diagnosing ocular diseases; retail store services featuring software for diagnosing ocular diseases; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for diagnosing ocular diseases; wholesale store services featuring software for diagnosing cardiovascular diseases; retail store services featuring software for diagnosing cardiovascular diseases; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for diagnosing cardiovascular diseases; wholesale store services featuring software for diagnosing kidney diseases; retail store services featuring software for diagnosing kidney diseases; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for diagnosing kidney diseases; wholesale store services featuring software for providing information relating to health; retail store services featuring software for providing information relating to health; sales agency services, namely, retail services by direct solicitation by sales agents featuring software for providing information relating to health; electronic data processing services relating to health care information; wholesale store services featuring apparatus for diagnosing cardiovascular diseases with artificial intelligence; retail store services featuring apparatus for diagnosing cardiovascular diseases with artificial intelligence; sales agency services, namely, retail services by direct solicitation by sales agents featuring apparatus for diagnosing cardiovascular diseases with artificial intelligence; wholesale store services featuring apparatus for diagnosing ocular diseases with artificial intelligence; retail store services featuring apparatus for diagnosing ocular diseases with artificial intelligence; sales agency services, namely, retail services by direct solicitation by sales agents featuring apparatus for diagnosing ocular diseases with artificial intelligence; wholesale store services featuring apparatus for diagnosing kidney diseases with artificial intelligence; retail store services featuring apparatus for diagnosing kidney diseases with artificial intelligence; sales agency services, namely, retail services by direct solicitation by sales agents featuring apparatus for diagnosing kidney diseases with artificial intelligence.

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Oct 1, 2026 OPNX
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2026 TROA
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Sep 16, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 16, 2026 OPNR
REFUSAL PROCESSED BY IB
Apr 2, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 19, 2026 RFCS
REFUSAL PROCESSED BY MPU
Mar 19, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 16, 2026 RFCR
NON-FINAL ACTION WRITTEN
Feb 14, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 24, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 23, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 23, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 17, 2025 REPR